---
title: "Cencora, Inc. (COR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/COR.US.md"
symbol: "COR.US"
name: "Cencora, Inc."
industry: "医疗产品分销商"
---

# Cencora, Inc. (COR.US)

| Item | Detail |
|------|--------|
| Industry | 医疗产品分销商 |
| Location | 美股市场 |
| Website | [www.cencora.com](https://www.cencora.com) |

## Company Profile

Cencora, Inc. 在美国和国际上采购和分销药品。该公司的美国医疗解决方案部门向急性护理医院和健康系统、独立和连锁零售药房、邮购药房、医疗诊所、长期护理和替代场所药房以及其他客户分销仿制药和注射药品、非处方医疗产品、家庭医疗用品和设备及相关服务；分销血浆和其他血液产品、疫苗以及其他特殊药品；提供药房管理、人员配备和其他咨询服务；向零售和机构医疗提供者提供供应管理软件；向机构和零售医疗提供者提供包装解决方案；提供临床试验支持、产品上市后和商业化支持服务；为生物技术和制药制造商提供数据分析、结果研究和其他服务；向伴侣动物和生产动物市场提供药品、疫苗、驱虫剂、诊断产品、微饲料成分及其他产品；...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-22T04:30:13.000Z

**Overall: B (0.36)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 15 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 7.45% |  |
| Net Profit YoY | 16.40% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 36.81 |  |
| Dividend Ratio | 0.64% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 70.24B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 325.78B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 152.25% | A |
| Profit Margin | 0.50% | C |
| Gross Margin | 3.57% | E |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 7.45% | C |
| Net Profit YoY | 16.40% | B |
| Total Assets YoY | 13.48% | B |
| Net Assets YoY | 479.15% | A |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 20045.20% | A |
| OCF YoY | 7.45% | C |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 4.42 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 97.33% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Cencora, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "152.25%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "0.50%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "3.57%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "7.45%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "16.40%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.48%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "479.15%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "20045.20%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "7.45%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "4.42",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "97.33%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Cencora (US.COR) | B | B | A | E | B | B |
| 02 | 亨利香恩 (US.HSIC) | B | C | A | D | B | B |
| 03 | 麦克森 (US.MCK) | E | B | A | E | A | C |
| 04 | 卡地纳健康 (US.CAH) | E | B | A | E | A | C |
| 05 | AdaptHealth (US.AHCO) | C | C | B | D | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 43.22 | 5/13 | 42.65 | 34.84 | 32.48 |
| PB | 36.81 | 8/13 | 57.89 | 45.60 | 31.29 |
| PS (TTM) | 0.22 | 2/13 | 0.21 | 0.19 | 0.18 |
| Dividend Yield | 0.64% | 2/13 | 0.75% | 0.73% | 0.65% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-19T05:00:00.000Z

Total Analysts: **16**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 10 | 63% |
| Overweight | 3 | 19% |
| Hold | 3 | 19% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 361.08 |
| Highest Target | 440.00 |
| Lowest Target | 315.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/COR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/COR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/COR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.